512 
MINUTES  OF  THE 
The  time  and  place  for  holding  the  next  meeting  was  taken 
up,  when  the  Secretary  read  the  following  telegram,  dated 
yesterday  : 
"The  Maryland  College  of  Pharmacy  extends  a  cordial  invitation  to 
the  American  Pharmaceutical  Association  to  meet  in  Baltimore  in  1870." 
Signed,  J.  J.  Smith. 
The  resolution  before  the  meeting  at  the  time  of  postponing 
the  subject,  was  that  the  next  meeting  be  held  at  Saratago 
Springs,  N.  Y. 
Mr.  Tufts  offered  an  amendment  to  substitute  Baltimore,  which 
was  carried,  and  the  amended  resolution  adopted,  so  that  the 
Association  will  adjourn  to  meet  in  Baltimore  on  the  2d  Monday 
of  September,  1870. 
The  nominating  Committee  reported  that  Mr.  Henry  W.  Ful- 
ler agreed  to  serve  as  Chairman  of  the  Committee  on  the  Drug 
Market,  and  had  withdrawn  his  declination. 
Mr.  Taylor  read  a  letter  from  D.  C.  Bobbins,  of  N.  Y.,  to 
H.  W.  Fuller.    Beferred  to  the  Executive  Committee. 
The  resolutions  offered  at  the  fifth  session,  concerning  Mr. 
Stearns,  were  called  up  and  read.    (See  page  507.) 
A  member  suggested  that  as  Mr.  Stearns  was  present,  it 
was  proper  for  him  to  make  a  statement  in  regard  to  the 
matter.  ^ 
Mr.  Stearns  then  came  forward  and  said  that  he  felt  it  was  due,  not 
only  to  himself  but  also  to  the  Association,  that  he  should  explain  where 
he  stood  in  the  matter  charged  against  him.  It  was  true  that  he  had 
put  a  speciality  in  the  market  under  the  trade  name  of  "  Sweet  Quinine," 
which  is  made  of  cinchonia.  He  felt  justified  in  doing  so  from  two  mo- 
tives ;  first  pecuniary  gain  to  himself;  second  a  belief  in  the  efficacy  of 
his  medicine.  He  then,  to  explain  the  maUer,  gave  a  statement  in  refer- 
ence to  the  history  of  the  introduction  of  quinine  by  Pelletier,  which,  in 
his  opinion,  caused  that  alkaloid  to  have  an  undue  degree  of  considera- 
tion in  medicine  and  turned  observation  away  from  cinchona,  which  had 
priority  of  discovery.  Believing,  therefore,  that  cinchona  possessed  the 
same  kind  of  curative  power  and  qualities  as  quinia,  he  thoughi.  ^  would 
be  a  good  thing  to  bring  it  into  use  and  thus  render  available  a  large 
amount  of  a  useful  agent  which  fashion  prevented  from  being  used  as  it 
deserved.  To  effect  this  purpose,  the  bringing  of  cinchonia  into  use  and 
thus  deriving  pecuniary  gain,  he  had  availed  himself  of  the  name  of 
Quinia  by  inference  in  adopting  the  trade  name  "  Sweet  Quinine."  This 
Constituted  his  offence  ;  he  considered  |it  an  error  of  poHcy,  rather  than 
